CHRNA7 and early-onset autosomal dominant Alzheimer disease: For example, RG3487, an α7-nAChR agonist and serotonin receptor antagonist, has shown efficacy in modulating cognitive function in rodents and holds potential for treating Alzheimer’s disease (Wallace et al., 2011).